Amrutanjan Health Care Q4 Results FY26 PAT Rs 16.19 crore Quarterly Performance Update

Amrutanjan Health Care Q4 results for FY26 reported consolidated net profit of Rs 16.19 crore. The Amrutanjan Health Care Q4 results were announced on May 8, 2026 by the pain relief and consumer healthcare, providing investors with insights into quarterly operational performance and business momentum.

The Amrutanjan Health Care Q4 FY26 performance reflects the consumer healthcare sector dynamics and the company’s specific positioning. The Amrutanjan Health Care Q4 results provide a snapshot of operational execution, demand trends, and FY27 outlook for stakeholders tracking this listed entity.

Get Free Stock Recommendations on Univest

Amrutanjan Health Care Q4 FY26 Results at a Glance

Metric	Q4 FY26	Change / Context
Net Profit/Loss PAT	Rs 16.19 crore	Q4 FY26 delivery
Business Segment	Consumer Healthcare	Core operations
Quarter	Q4 FY26	Ended March 31, 2026
Results Announced	May 8, 2026	Board meeting
Company Type	Listed Indian company	BSE/NSE
Sector	Pain Relief And Consumer Healthcare	Indian market

Track live Amrutanjan Health Care financials, analyst ratings and peer comparisons on the Univest Screener.

Key Highlights from Amrutanjan Health Care Q4 FY26 Results

Amrutanjan Health Care Q4 FY26 Performance Snapshot

The quarterly results reflect the company’s positioning in the consumer healthcare segment. The performance captures the prevailing demand environment, cost trends, and execution quality. The reported profit of Rs 16.19 crore provides the baseline for assessing FY27 trajectory and recovery or growth potential.

Sector and Business Context

The company operates as a leading consumer healthcare company with Amrutanjan pain balm and Comfy feminine hygiene. The performance should be read in the context of broader consumer healthcare sector trends, competitive dynamics, and macroeconomic factors affecting demand and profitability. Strategic positioning and operational levers will determine the FY27 performance trajectory.

What Drove Amrutanjan Health Care Q4 FY26 Performance

The Amrutanjan Health Care Q4 results were shaped by consumer healthcare sector demand trends, input cost dynamics, and operational execution. Business performance reflects competitive positioning, customer engagement, and cost management capabilities. Continued growth depends on sustained demand and operational efficiency.

Outlook for FY27 After Amrutanjan Health Care Q4 Results

Following the Amrutanjan Health Care Q4 results FY26, the FY27 outlook depends on consumer healthcare sector recovery, demand momentum, and operational execution. The FY27 trajectory will be shaped by management strategy, market conditions, and competitive dynamics. Investors should track quarterly performance and management commentary on growth drivers.

Conclusion

Amrutanjan Health Care Q4 results FY26 delivered consolidated PAT of Rs 16.19 crore from consumer healthcare operations. The results provide a snapshot of business delivery and FY27 baseline. Investors tracking the Amrutanjan Health Care Q4 results should watch sector demand trends, operational execution, and strategic initiatives ahead.

Download the Univest iOS App or Univest Android App for live Q4 results tracking and expert research.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. Univest analysts are SEBI-registered research analysts (SEBI RA: INH000012449). Verify all numbers before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions

What was Amrutanjan Health Care Q4 FY26 PAT?

The Amrutanjan Health Care Q4 results FY26 reported consolidated net profit of Rs 16.19 crore from pain relief and consumer healthcare operations during the quarter ended March 31, 2026.

What does Amrutanjan Health Care do?

Amrutanjan Health Care operates as a leading consumer healthcare company with Amrutanjan pain balm and Comfy feminine hygiene. This positioning is reflected in the operational and business performance disclosures during the quarter.

When were Amrutanjan Health Care Q4 FY26 results announced?

The Amrutanjan Health Care Q4 results FY26 were announced on May 8, 2026, by the company’s board of directors at a duly convened board meeting, in compliance with SEBI listing disclosure requirements.

What are key drivers for Amrutanjan Health Care?

Key drivers visible in the Amrutanjan Health Care Q4 results FY26 include consumer healthcare sector demand dynamics, operational efficiency, input cost management, and competitive positioning in primary markets.

What is Amrutanjan Health Care FY27 outlook?

The FY27 outlook depends on sector demand recovery, operational execution, and strategic initiatives. Investors should monitor quarterly performance and management commentary on growth and expansion plans.

Recent Article

Heritage Foods Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks

ICICI Lombard General Insurance Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks

Indoco Remedies Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks

Niva Bupa Health Insurance Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks

Gujarat Fluorochemicals Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks